根据最终合并协议,Viewpoint的每一股已发行和流通股份将转换为获得Isoray 3.3212股的权利。Viewpoint股东将拥有Isoray完全稀释的流通股49%的股份。
$华海药业(SH600521)$ $华东医药(SZ000963...查看全文
$ISORAY INC(ISR)$ S-3/A [Amend] - Registration statement under Securities Act of 1933 Filed: 2015-11-19 AccNo: 0001144204-15-066961 Size: 82 KB 网页链接
$ISORAY INC(ISR)$ CT ORDER - Confidential treatment order Filed: 2015-11-17 AccNo: 9999999997-15-014665 Size: 17 KB 网页链接
$ISORAY INC(ISR)$ 8-K - Current report Filed: 2015-11-10 AccNo: 0001144204-15-063974 Size: 69 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$ISORAY INC(ISR)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2015-11-09 AccNo: 0001144204-15-063851 Size: 3 MB 网页链接
$ISORAY INC(ISR)$ SD - Filed: 2015-06-01 AccNo: 0001144204-15-034892 Size: 18 KB 网页链接
$ISORAY INC(ISR)$ S-3/A [Amend] - Registration statement under Securities Act of 1933 Filed: 2015-10-09 AccNo: 0001144204-15-058929 Size: 288 KB 网页链接
$ISORAY INC(ISR)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2015-08-25 AccNo: 0001144204-15-051749 Size: 284 KB 网页链接
$ISORAY INC(ISR)$ CT ORDER - Confidential treatment order Filed: 2015-06-23 AccNo: 9999999997-15-011044 Size: 14 KB 网页链接
$ISORAY INC(ISR)$ 8-K - Current report Filed: 2015-09-15 AccNo: 0001144204-15-054939 Size: 66 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$ISORAY INC(ISR)$ 8-K - Current report Filed: 2015-09-02 AccNo: 0001144204-15-053471 Size: 12 KBItem 1.01: Entry into a Material Definitive Agreement 网页链接